Biological Information

Background Information:

Protein serine threonine kinase N1 (PKN1) is a fatty acid and Rho-activated serine/threonine protein kinase whose catalytic domain is highly homologous to protein kinase C (PKC) family. PKN1 is reported to mediate cellular response to stress and involved in TRAF2-NF-kappaB signaling pathway.

Family:

Kinase

Sub Family:

AGC

Class:

Protein Ser/Thr

Protein Name:

PKN1

Uniprot Number:

Q16512

Protein Aliases:

Protease-activated kinase 1|PAK-1|Protein kinase C-like 1|Protein kinase C-like PKN|Protein kinase PKN-alpha|Protein-kinase C-related kinase 1|Serine-threonine protein kinase N

Gene Name:

PKN1

Gene ID:

5585

Gene Aliases:

DBK|PRK1|PKN|MGC46204|PAK1

Organism:

Human

Construct Details:

498-end; V901I recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Enzymatic

Functional Mode:

Antagonist

Detection Method:

Radiometric

Measured Response:

Scintillation

Testing Information

Procedure Summary:

PRK1(h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 µM KKLNRTLSFAEPG, 10 mM Magnesium acetate and [gamma-33P-ATP] (specific activity and concentration as required). The reaction is initiated by the addition of the Mg/ATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of phosphoric acid to a concentration of 0.5%. An aliquot of the reaction is then spotted onto a filter and washed four times for 4 minutes in 0.425% phosphoric acid and once in methanol prior to drying and scintillation counting.

Substrate:

250 uM KKLNRTLSFAEPG

Tracer:

33P

ATP Concentration:

[ATP]= 10µM (Km= 49µM )

Incubation:

40 min at Room temperature

Control Inhibitor:

PKR Inhibitor

Test Sample Requirements:

Please provide compounds dissolved in 100% DMSO (PBS or HBSS prohibited).
Stock solution should be ≥50× the final assay concentration (a 10 mM stock is also acceptable).
Required volume:
– <60 kinase assays: 120 µL of 50× stock
– ≥60 assays: 420 µL of 50× stock
If you supply 10 mM stocks or powder (pre-weighed), we will apply the appropriate conversion.
For batches of ~50 compounds supplied as solids, the TAT will be extended.

Minimum Order Quantity:

2

Turnaround Time

Standard:

6 Business Days

Service Scheduling Note:

Assay is run on a weekly schedule beginning on Friday.  Compounds and purchase order must be received on or before 13:00 CET Thursday for the order to be included on the service run that begins on Friday of the same week.

Reference Compound Data

PubChem ID

6490494

Name

PKR Inhibitor

Measurement

128.33nM - IC50

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Adverse / Beneficial Action:

Inhibition of PKN1 may be useful in the treatment of prostate cancer and other tumors as well as reverse decreased cerebral and myocardial blood flow due to vasospam.

Additional Information

Brand:

LeadHunter

Testing Location:

KP - France - Celle L'Evescault

RELATED SOLUTIONS

Item: 15-029KP